Investigation Report on China's Insulin Aspart Market, 2018-2022

Publisher Name :
Date: 01-Nov-2018
No. of pages: 30

Description

The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It is estimated that at the end of 2017, there were more than 100 million diabetic patients in China. The market size of diabetes drugs is also growing in China.

On Dec. 26, 2001, Novo Nordisk announced that Insulin Aspart (trade name: NovoRapid), the first and only insulin analog that can be used with insulin pumps, was approved by the FDA. Insulin Aspart starts working in 10 to 20 minutes after subcutaneous injection and can reduce postprandial blood glucose and glycated hemoglobin (HbA1c). On the basis of Insulin Aspart, Novo Nordisk developed premixed insulin aspart containing soluble insulin aspart and protaminated insulin aspart of various proportions. The combination of the fast-acting form and the long-acting form allows patients to receive fewer injections over the course of the day. NovoLog Mix 70/30, containing 30% soluble insulin aspart and 70% protaminated insulin aspart, was approved by the FDA in Nov. 2001. Similar NovoLog Mix 50/50 was approved by the FDA in Aug. 2008. In Apr. 2005, NovoMix 30 (30% soluble insulin aspart and 70% protaminated insulin aspart), the first premixed insulin analog, was launched in China. According to CRI, from 2005 to 2017, the sales value of Insulin Aspart in China grew by over 100 times. The market size of Insulin Aspart in China exceeded CNY 200 million in 2017.

Because there are high technical barriers against the imitation of Insulin Aspart, by Oct. 2018, China's Insulin Aspart market is monopolized by Novo Nordisk's Insulin Aspart (NovoRapid). According to CRI, several Chinese companies are applying for the CFDA's approval for generic Insulin Aspart. However, the launch of generic drugs will take several years. With an increasing number of diabetic patients, the market size of Insulin Aspart in China will maintain rapid growth in the next few years.

Topics Covered:


  • Situation of diabetes in China

  • Sales of Insulin Aspart in China

  • Prices of Insulin Aspart in China

  • Progress of generic Insulin Aspart in China

  • Prospect of China's Insulin Aspart market from 2018 to 2022

Investigation Report on China's Insulin Aspart Market, 2018-2022

Table of Contents

1 Relevant Concepts of Insulin Aspart
1.1 Indications for Insulin Aspart
1.2 Development of Insulin Aspart in China
1.3 Patents and Government Approval on Insulin Aspart in China

2 Sales of Insulin Aspart in China, 2013-2017
2.1 Sales Value of Insulin Aspart
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Insulin Aspart
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Insulin Aspart by Dosage Form in China, 2013-2017

3 Analysis on Major Insulin Aspart Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Insulin Aspart Manufacturers
3.2 Novo Nordisk
3.2.1 Enterprise Profile
3.2.2 Sales of Novo Nordisk's Insulin Aspart in China

4 Prices of Insulin Aspart in China, 2017-2018
4.1 Novo Nordisk (NovoRapid)
4.2 Progress of Generic Drugs

5 Prospect of China's Insulin Aspart Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Sales of Insulin Aspart in China, 2013-2017
Chart Sales Value of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Volume of Insulin Aspart in China, 2013-2017
Chart Sales Volume of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Value of Insulin Aspart Injections in China, 2013-2017
Chart Sales Volume of Insulin Aspart Injections in China, 2013-2017
Chart Sales Value of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Sales Volume of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Prices of Novo Nordisk's Insulin Aspart (NovoRapid) in Parts of China in 2017

  • Global Glucagon Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Feb-2019        Price: US 3480 Onwards        Pages: 124
    Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release s......
  • Global Antidiabetic Biguanides Industry Market Research Report
    Published: 18-Feb-2019        Price: US 2960 Onwards        Pages: 116
    The Antidiabetic Biguanides market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Antidiabetic Biguanides industrial chain, this report mainly elaborates the definition, types, applications and major players of Antidiabetic Biguanides market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise Prod......
  • Global Next Generation Diabetes Therapy and Drug Delivery Industry Market Research 2019
    Published: 15-Feb-2019        Price: US 2600 Onwards        Pages: 148
    In this report, we analyze the Next Generation Diabetes Therapy and Drug Delivery industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions f......
  • Global Liraglutide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 14-Feb-2019        Price: US 3480 Onwards        Pages: 119
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global Diabetic Therapeutic Industry Market Research 2019
    Published: 14-Feb-2019        Price: US 2600 Onwards        Pages: 160
    In this report, we analyze the Diabetic Therapeutic industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make......
  • Global Diabetes Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 14-Feb-2019        Price: US 3480 Onwards        Pages: 135
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • Global Antidiabetic SGLT-2 Inhibitor Market Insights, Forecast to 2025
    Published: 14-Feb-2019        Price: US 3900 Onwards        Pages: 117
    The global Antidiabetic SGLT-2 Inhibitor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antidiabetic SGLT-2 Inhibitor market based on company, product type, end user and key regions. This report studies the global market size of Antidiabetic SGLT-2 Inhibitor in key regions like North America, Europe, Asia Pacific, Central &......
  • Global Glucagon like peptide-1 (GLP-1) agonists Market Insights, Forecast to 2025
    Published: 14-Feb-2019        Price: US 3900 Onwards        Pages: 116
    The global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucagon Like Peptide-1 (GLP-1) Agonists market based on company, product type, end user and key regions. This report studies the global market size of Glucagon Like Peptide-1 (GLP-1) Agonists in key regions like North America......
  • Global Diabetes Drugs Market Growth 2019-2024
    Published: 14-Feb-2019        Price: US 3660 Onwards        Pages: 163
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs